HAEMOSIDEROSIS

This adverse event was reported 268 times

HAEMOSIDEROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ALBENDAZOLE 18 0.0095
1 DEFEROXAMINE MESYLATE 17 0.0078
2 MEXILETINE HYDROCHLORIDE 1 0.0024
3 SODIUM THIOSULFATE 1 0.0018
4 DEFERASIROX 45 0.0017
5 HEMIN 1 0.0017
6 ORPHENADRINE CITRATE 1 0.0016
7 SILTUXIMAB 1 0.0015
8 IRON DEXTRAN 2 0.0013
9 IBRITUMOMAB TIUXETAN 2 0.0013
See all drugs enriched for association with HAEMOSIDEROSIS

HAEMOSIDEROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anthelmintic [EPC] 18 0.0062
1 Iron Chelator [EPC] 46 0.0016
2 Interleukin-6 Antagonist [EPC] 1 0.0015
3 Bile Acid [EPC] 24 0.0010
4 Erythroid Maturation Agent [EPC] 2 0.0008
5 Selectin Blocker [EPC] 1 0.0007
6 Antimalarial [EPC] 5 0.0005
7 Antiprotozoal [EPC] 5 0.0005
8 Somatostatin Analog [EPC] 3 0.0004
9 Thyroid Hormone Receptor beta Agonist [EPC] 1 0.0004
See all drug classes enriched for association with HAEMOSIDEROSIS